InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+13.6%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Wellborn Gayle Furgurson, Director. Director active across 1 company, notably Healthequity, INC.. Aggregated, 9 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €306k. Activity tracked since 1 February 2022. The latest transaction was filed on 9 July 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
2,877 sharesCommon StockSEC:0001712960-26-000004:0
5,297 shares@ US$47.2143.1% of flowCommon StockSEC:0001415889-24-019483:0
2,543 shares0Common StockSEC:0001415889-24-019409:0
3,164 shares0Common StockSEC:0001415889-23-010324:0
5,237 shares@ US$62.0056.9% of flowCommon StockSEC:0001415889-22-012624:0
2,996 shares0Common StockSEC:0001415889-22-006997:0
1,455 shares0Common StockSEC:0001179110-22-002747:0
727 shares0Common StockSEC:0001179110-22-000753:0
727 shares0Common StockSEC:0001179110-22-000753
9 of 9 declarations
About Wellborn Gayle Furgurson
Gayle Furgurson Wellborn is a Director at HEALTHEQUITY, INC. She brings extensive experience in corporate governance and strategy. As a director, Gayle contributes to the direction and oversight of the company's activities, ensuring they align with best practices and strategic objectives. Her expertise in the healthcare sector is a valuable asset for HEALTHEQUITY, INC.
